Recruiting
Phase 2

Abiraterone & Darolutamide

Sponsor:

Mamta Parikh

Code:

NCT06173362

Conditions

Advanced Prostate Adenocarcinoma

Stage III Prostate Cancer AJCC v8

Stage IV Prostate Cancer AJCC v8

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Abiraterone

Biospecimen Collection

Darolutamide

Prednisone

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by Mamta Parikh on 2024-12-18.